Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

Rhea-AI Summary

Xeris Biopharma Holdings, Inc. (XERS) to present at Oppenheimer 34th Annual Healthcare Life Sciences Conference. CEO Paul R. Edick to provide an overview on February 13, 2024, at 10:00 am Eastern Time. Interested individuals can access the presentation on the investor relations page of the company's website.

CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris’ Chairman and CEO, will present an overview of the Company at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024 at 10:00 am Eastern Time. To access the presentation, please visit “Events” on the investor relations page of the Company’s website at www.xerispharma.com.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products; Gvoke^®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis^®, a proven therapy for primary periodic paralysis, and Recorlev^® for the treatment of endogenous Cushing’s syndrome. Xeris also has a robust pipeline of development programs to extend the current marketed products into important new indications and uses and bring new products forward using its proprietary formulation technology platforms, XeriSol™ and XeriJect^®, supporting long-term product development and commercial success.

Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205852546/en/

Allison Wey

Senior Vice President, Investor Relations and Corporate Communications

awey@xerispharma.com

Source: Xeris Biopharma Holdings, Inc.

When is Xeris Biopharma Holdings, Inc. (XERS) presenting at the Oppenheimer 34th Annual Healthcare Life Sciences Conference?

Xeris Biopharma Holdings, Inc. (XERS) is presenting at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024, at 10:00 am Eastern Time.

Who will be providing the overview of Xeris Biopharma Holdings, Inc. at the conference?

Paul R. Edick, Xeris' Chairman and CEO, will be providing the overview at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Where can interested individuals access the presentation?

Interested individuals can access the presentation on the investor relations page of the company's website at www.xerispharma.com.